Acetic Acid → (S)-4-[3-((S)-4-Hydroxy-6-aza-spiro[2.5]oct-6-yl)-propyl]-2-methyl-3-oxo-piperazine-1-carboxylic acid (3,4-dichloro-phenyl)-amide

HRID 655557Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 655557
C(=O)([O-])O.[Na+].[Cl:6][C:7]1[CH:8]=[C:9]([NH:14][C:15]([N:17]2[CH2:22][CH2:21][N:20]([CH2:23][CH2:24][CH2:25]O)[C:19](=[O:27])[C@@H:18]2[CH3:28])=[O:16])[CH:10]=[CH:11][C:12]=1[Cl:13].[Br-].[K+].Cl[O-].[Na+].Cl.[CH2:35]1[C:37]2([CH2:42][CH2:41][NH:40][CH2:39][C@H:38]2[OH:43])[CH2:36]1.C(N(CC)CC)C.C(O)(=O)C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].N>ClCCl.CC1(C)N([O])C(C)(C)CCC1>[Cl:6][C:7]1[CH:8]=[C:9]([NH:14][C:15]([N:17]2[CH2:22][CH2:21][N:20]([CH2:23][CH2:24][CH2:25][N:40]3[CH2:41][CH2:42][C:37]4([CH2:35][CH2:36]4)[C@H:38]([OH:43])[CH2:39]3)[C:19](=[O:27])[C@@H:18]2[CH3:28])=[O:16])[CH:10]=[CH:11][C:12]=1[Cl:13]

Komponenten

12

Edukt 9

HCID 176Acetic AcidHCID 222AmmoniaHCID 8471TriethylamineHCID 253877Potassium BromideHCID 516892Sodium BicarbonateHCID 5049666Sodium triacetoxyborohydrideHCID 23665760Sodium HypochloriteHCID 44541812(4S)-6-Azaspiro[2.5]octan-4-ol hydrochloride2×HCID 67080598(S)-4-(3-Hydroxy-propyl)-2-methyl-3-oxo-piperazine-1-carboxylic acid (3,4-dichloro-phenyl)-amide2×

Produkt 1

HCID 44612134(S)-4-[3-((S)-4-Hydroxy-6-aza-spiro[2.5]oct-6-yl)-propyl]-2-methyl-3-oxo-piperazine-1-carboxylic acid (3,4-dichloro-phenyl)-amideAusbeute 38,2 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 2724126TempoKatalysatorHCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

Saturated aq. sodium hydrogencarbonate solution (0.13 ml) was added to a solution of (S)-4-(3-hydroxy-propyl)-2-methyl-3-oxo-piperazine-1-carboxylic acid (3,4-dichloro-phenyl)-amide (intermediate 21; 95 mg, 0.26 mmol), potassium bromide (3 mg, 0.03 mmol), and 2,2,6,6-tetramethylpiperidin-1-oxyl (0.4 mg, 0.003 mmol) in dichloromethane (5 ml). Sodium hypochlorite solution (10% in water, 0.16 ml, 0.26 mmol) was added portionwise at 0° C., and the course of the oxidation was monitored by thin layer chromatography. After all starting material had reacted, the reaction mixture was washed with sat. aq. sodium hydrogencarbonate solution, and the aqueous layer was extracted twice with dichloromethane. The organic phases were pooled, dried (MgSO4), filtered, and evaporated, thus affoding (S)-2-methyl-3-oxo-4-(3-oxo-propyl)-piperazine-1-carboxylic acid (3,4-dichloro-phenyl)-amide (75 mg). This was dissolved in dichloromethane (2 ml) and added over 20 min to a suspension of (S)-6-aza-spiro[2.5]octan-4-ol hydrochloride (intermediate 2; 39 mg, 0.24 mmol) triethylamine (25 mg, 0.25 mmol), acetic acid (29 mg, 0.48 mmol) and sodium triacetoxyborohydride (58 mg, 0.26 mmol) in dichloromethane (2 ml). After 16 h the reaction mixture was treated with 25% aq. ammonia solution (70 μL, 0.48 mmol) and evaporated. Chromatography (SiO2; dichloro-methane/methanol/25% aq. ammonia solution 90:10:0.25) produced the title compound (43 mg, 35%). White solid, MS (ISP)=469.3 (M+H)+.

Aufarbeitung

  1. customAfter all starting material had reacted
  2. washthe reaction mixture was washed with sat. aq. sodium hydrogencarbonate solution
  3. extractionthe aqueous layer was extracted twice with dichloromethane
  4. dry with materialdried (MgSO4)
  5. filtrationfiltered
  6. customevaporated
  7. dissolutionThis was dissolved in dichloromethane (2 ml)
  8. customevaporated

Quellen und Nachweise

ORD-Eintrag
ord-9d258ee8964a4c64a1700e00d17e4688
Quelldatensatz
uspto-grants-2011_12
Patentnummer
US08071586B2

Notizen zur Reaktion

Wird geladen…